Diabetes Supply

Novo Nordisk ( NVO ) has secured U.S. Food and Drug Administration approval for Victoza, its type 2 diabetes treatment for adults. The company, which has waited since May 2008 for the approval, expects to start marketing the drug within weeks Read More About Diabetes

This entry was posted on Thursday, February 4th, 2010 at 11:00 pm and is filed under Diabetes Mellitus. You can subscribe via RSS 2.0 feed to this post's comments. You can skip to the end and leave a response. Pinging is currently not allowed.